Humana Inc. (HUM) Plans $0.40 Quarterly Dividend
Humana Inc. (NYSE:HUM) declared a quarterly dividend on Thursday, August 17th, RTT News reports. Stockholders of record on Tuesday, August 29th will be given a dividend of 0.40 per share by the insurance provider on Friday, October 27th. This represents a $1.60 annualized dividend and a dividend yield of 0.65%.
Humana has raised its dividend payment by an average of 3.1% per year over the last three years and has increased its dividend annually for the last 6 consecutive years. Humana has a dividend payout ratio of 13.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $12.22 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 13.1%.
Humana (NYSE HUM) traded up 0.12% during trading on Thursday, hitting $247.66. The stock had a trading volume of 748,684 shares. The company has a market cap of $35.79 billion, a PE ratio of 20.37 and a beta of 0.91. The stock has a 50-day moving average price of $240.60 and a 200-day moving average price of $224.06. Humana has a 52 week low of $163.50 and a 52 week high of $255.27.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same quarter in the previous year, the company posted $2.30 earnings per share. Equities analysts predict that Humana will post $11.55 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/17/humana-inc-hum-plans-0-40-quarterly-dividend.html.
In other news, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction dated Friday, May 26th. The shares were sold at an average price of $231.96, for a total transaction of $347,940.00. Following the transaction, the vice president now directly owns 8,150 shares in the company, valued at approximately $1,890,474. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. Insiders have sold a total of 41,406 shares of company stock worth $10,355,086 over the last three months. Insiders own 0.80% of the company’s stock.
A number of research analysts have recently issued reports on HUM shares. Zacks Investment Research cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Monday, April 24th. Citigroup Inc. assumed coverage on shares of Humana in a research note on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price for the company. Evercore ISI reissued an “outperform” rating and issued a $240.00 price target on shares of Humana in a report on Tuesday, April 25th. BidaskClub raised shares of Humana from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $230.00 price target (up previously from $221.00) on shares of Humana in a report on Thursday, May 4th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $244.35.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.